| December 22, 2004 |
December 22, 2004
Cerus Acquires Additional Rights to Mesothelin Cancer Antigen from Chugai Pharmaceutical
|
| December 20, 2004 |
December 20, 2004
Cerus Corporation Announces Transition of John Hearst
|
| December 3, 2004 |
December 3, 2004
Cerus Corporation and Collaborators to Present at American Society of Hematology Meeting
|
| November 9, 2004 |
November 9, 2004
Cerus Corporation Announces Third Quarter Results
|
| October 26, 2004 |
October 26, 2004
Cerus Corporation to Webcast Third Quarter Financial Results Conference Call
|
| October 22, 2004 |
October 22, 2004
Cerus Corporation to Present at Rodman & Renshaw Techvest 6th Annual Healthcare Conference
|
| October 14, 2004 |
October 14, 2004
Baxter and Cerus Announce Closure of Transaction with BioOne Corporation
|
| September 22, 2004 |
September 22, 2004
Preclinical Results Demonstrate Potential Therapeutic and Safety Benefits of Cerus' Cancer Immunotherapy Technology
|
| July 29, 2004 |
July 29, 2004
Baxter and Cerus Enter Agreement with Asian Partner for Commercialization of INTERCEPT Blood System for Platelets
|
| July 29, 2004 |
July 29, 2004
Cerus Corporation Announces Second Quarter Results
|
| July 28, 2004 |
July 28, 2004
Cerus Appoints William J. Dawson as Vice President, Finance and Chief Financial Officer
|
| July 28, 2004 |
July 28, 2004
Cerus Awarded NIH Grant to Develop Anthrax Vaccine
|
| July 22, 2004 |
July 22, 2004
Cerus Corporation Invites You to Join a Webcast of its Second Quarter Financial Results Conference Call
|
| June 30, 2004 |
June 30, 2004
Cerus Increases Development Focus on Therapeutic Vaccines
|
| June 14, 2004 |
June 14, 2004
Cerus Reports Initial Results from Additional Analysis of the U.S. Phase III Data for the INTERCEPT Blood System for Platelets
|
| May 19, 2004 |
May 19, 2004
Cerus Reports Phase III Results for the INTERCEPT Plasma System
|
| May 3, 2004 |
May 3, 2004
Cerus Appoints Claes Glassell As President And Chief Executive Officer
|
| May 3, 2004 |
May 3, 2004
Cerus Corporation Announces First Quarter Results
|
| April 28, 2004 |
April 28, 2004
Cerus Announces Scientific Advisory Board for Therapeutic Vaccine Development
|
| April 26, 2004 |
April 26, 2004
Cerus Corporation Invites You to Join a Webcast of its First Quarter Financial Results Conference Call
|
| April 21, 2004 |
April 21, 2004
MedImmune and Cerus Enter Agreement to Co-Develop Therapeutic Vaccine for Cancer
|
| January 29, 2004 |
January 29, 2004
Cerus Corporation Announces Fourth Quarter And Year-End Results
|
| January 28, 2004 |
January 28, 2004
Cerus Corporation Acquires Rights to Cancer Antigen and Receives Phase I SBIR Grant
|
| January 26, 2004 |
January 26, 2004
Cerus Corporation Invites You to Join a Webcast of its Fourth Quarter and Year End Financial Results Conference Call
|